119$/KG
99$/KG
| CAS NO.: 117-39-5 | Authentication:COA,MSDS,FDA,Kosher,Halal etc. | Assay method: HPLC | Dosage form: liposomal powder, water-dispersible |
| Appearance: Yellow to yellow-green fine powder | Lead Time: In stock: 3–5 business days; Bulk/custom orders: 2–3 weeks | ||
| Recommended Dosage: 250–1,000 mg per day; clinical studies have evaluated quercetin at 500 mg/day and up to 2,000 mg/day | |||
| Extract Source: Sophora japonica L. flower bud extract (or other plant sources including apple, onion, and green tea) | |||
| Storage: Cool, dry place away from direct sunlight, heat, and moisture; keep container tightly sealed. Shelf life: 24 months | |||
| Application: Immune support, antioxidant defense, anti-inflammatory support, cardiovascular health, metabolic function, anti-aging, allergy support | |||
Premium Liposomal quercetin 70% Cellular Defense and Anti-Inflammatory Formula
Product Detailed Description
Liposomal Quercetin 70% is a premium-grade dietary supplement ingredient delivering quercetin in an advanced liposomal delivery system. Quercetin is a pentahydroxyflavone (3,3′,4′,5,7-pentahydroxyflavone) belonging to the flavonol subclass of flavonoids, with the molecular formula C₁₅H₁₀O₇ and a molecular weight of 302.24 g/mol. It is one of the most abundant flavonoids in edible vegetables, fruits, and wine, and is widely distributed in apples, onions, berries, green tea, and herbal medicines.
Quercetin has been extensively studied for its broad-spectrum pharmacological activities, including antioxidant, anti-inflammatory, anti-allergic, cardioprotective, neuroprotective, and senotherapeutic effects. It acts through multiple mechanisms, including activation of the Nrf2/ARE antioxidant response pathway and inhibition of NF-κB and the NLRP3 inflammasome. However, its clinical potential is severely limited by extremely poor water solubility and low oral bioavailability. Liposomal encapsulation addresses these challenges by protecting quercetin from degradation and enhancing its delivery to target cells.
Conventional quercetin presents significant formulation challenges due to its poor aqueous solubility (less than 10 μg/mL), limited solubility in organic solvents, and poor stability under conditions of light, high temperature, and high humidity. Following oral administration, its bioavailability is low due to low solubility and easy metabolism in the gastrointestinal tract, with most quercetin being metabolized by intestinal flora or excreted with feces before absorption.
Liposomal encapsulation provides three critical advantages:
1. Solubility and Stability Enhancement — By encapsulating quercetin within a phospholipid bilayer, its solubility and stability are significantly improved. The phospholipid bilayer structure protects quercetin from the influence of the external environment while making it more dispersible in water, showing properties similar to colloidal solutions.
2. Digestive Protection — The liposomal membrane shields quercetin from enzymatic degradation and premature metabolism in the gastrointestinal tract, preserving its intact molecular structure until reaching target cells.
3. Enhanced Cellular Uptake — liposomes fuse directly with intestinal cell membranes, facilitating efficient cellular delivery and bypassing passive diffusion limitations. By encapsulating quercetin in liposomes, its stability, solubility, and bioavailability can be improved, making it have better application prospects in the fields of medicine and health products.
| Field | Details |
|---|---|
| Product Name | Liposomal Quercetin 70% |
| CAS No. | 117-39-5 |
| Active Ingredient | Quercetin (3,3′,4′,5,7-Pentahydroxyflavone) |
| Assay Method | RP-HPLC with C18 column; mobile phase 1.5% acetic acid and water/acetonitrile/methanol (55:40:5); detection at 368 nm; LC-MS/MS for identity confirmation |
| Purity | ≥ 70% quercetin (HPLC); ≥ 95% assay available |
| Appearance / Color | Yellow to yellow-green fine powder |
| Dosage Form | Liposomal powder, water-dispersible |
| Recommended Dosage | 250–1,000 mg per day; clinical studies have evaluated quercetin at 500 mg/day and up to 2,000 mg/day |
| Application | Immune support, antioxidant defense, anti-inflammatory support, cardiovascular health, metabolic function, anti-aging, allergy support |
| Extract Source | Sophora japonica L. flower bud extract (or other plant sources including apple, onion, and green tea) |
| Molecular Formula | C₁₅H₁₀O₇ |
| Molecular Weight | 302.24 g/mol |
| Lead Time | In stock: 3–5 business days; Bulk/custom orders: 2–3 weeks |
| Shipping Method | International Express (FedEx / DHL / UPS); air and sea freight available; worldwide shipping including remote areas |
| Storage | Cool, dry place away from direct sunlight, heat, and moisture; keep container tightly sealed. Shelf life: 24 months |
High Purity — Standardized to ≥70% quercetin by HPLC, ensuring consistent active content.
Liposomal Enhancement — Sunflower phospholipid bilayer encapsulation significantly improves quercetin's solubility, stability, and bioavailability compared to standard quercetin.
Senotherapeutic Activity — Quercetin exhibits dual senolytic (selectively eliminating senescent cells) and senomorphic (modulating the harmful effects of these cells) capabilities, targeting the fundamental biological hallmarks of aging.
Antioxidant and Anti-Inflammatory — Quercetin activates the Nrf2/ARE signaling pathway, inducing endogenous antioxidant enzymes, while inhibiting NF-κB and the NLRP3 inflammasome.
Immunomodulatory Effects — Quercetin modulates the MAPK signaling pathway, shifts macrophage polarization from pro-inflammatory M1 to anti-inflammatory M2, and regulates immune responses.
Water-Dispersible — Suitable for capsules, tablets, powder drink mixes, and functional beverages.
Batch Traceability — Complete COA, HPLC chromatogram, and identity data provided for each batch.
| Application | Recommended Usage | Notes |
|---|---|---|
| Capsules / Tablets | 250–500 mg per serving | Take with meals to enhance absorption |
| Functional Beverages | 100–250 mg per 250 mL | Water-dispersible; suitable for RTD formats |
| Powdered Drink Mixes | 250–500 mg per sachet | Blend with vitamin C for synergistic antioxidant support |
| Immune Support Formulas | 250–500 mg per serving | Often combined with zinc, vitamin C, or elderberry |
| Anti-Aging / Longevity Formulas | 250–500 mg per serving | Senolytic activity may support cellular rejuvenation |
Clinical studies have evaluated quercetin at doses ranging from 500 mg per day to 2,000 mg per day. A randomized controlled trial in patients with Type 2 Diabetes Mellitus demonstrated that 500 mg of daily quercetin supplementation over 32 weeks improved glycated hemoglobin (HbA1c), reduced systolic blood pressure, and improved lung function, sleep quality, anxiety levels, and overall quality of life. A pilot Phase II clinical trial in COPD patients used quercetin at 2,000 mg/day for 6 months and found it to be safely tolerated. A Phase 1 study in children and young adults with Fanconi anemia established a recommended dose with a maximum adult daily dose of 4,000 mg/d. For general antioxidant and immune support, 500 mg daily is commonly used. Liposomal formulations may allow for more efficient utilization of lower doses due to enhanced bioavailability.
Stock Orders: 3–5 business days after payment confirmation.
Bulk / Custom Orders: 2–3 weeks, depending on quantity and customization requirements.
Shipping Methods: International Express (FedEx, DHL, UPS), air freight, and sea freight.
Coverage: Worldwide shipping, including remote areas.
Quercetin Encyclopedia — Scientific Background
Quercetin is a pentahydroxyflavone having five hydroxy groups placed at the 3-, 3′-, 4′-, 5-, and 7-positions. It is one of the most abundant flavonoids in edible vegetables, fruits, and wine, and is classified as a flavonol—a subclass of flavonoids characterized by a 3-hydroxyflavone backbone. Quercetin is found in plants in free form or in the form of glycosides combined with sugars.
| Property | Value |
|---|---|
| CAS No. | 117-39-5 |
| Molecular Formula | C₁₅H₁₀O₇ |
| Molecular Weight | 302.24 g/mol |
| IUPAC Name | 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one |
| Appearance | Yellow to yellow-green crystalline powder |
| Solubility | Poorly soluble in water (< 10 μg/mL); soluble in ethanol and alkaline solutions |
| Melting Point | 316–317°C |
Quercetin is widely distributed in the plant kingdom and is found in numerous edible plants:
Sophora japonica (Japanese Pagoda Tree) — The primary commercial source for high-purity quercetin extraction, particularly the flower buds
Apples — Especially in the skin
Onions — One of the richest dietary sources, particularly red onions
Berries — Including blueberries, cranberries, and blackcurrants
Green Tea — Contains quercetin alongside catechins
Red Wine — A notable dietary source
Quercetin protects cells from oxidative stress by activating the Nrf2/antioxidant response element (ARE) pathway. It significantly increases the expression of Trx-1 at the mRNA and protein levels, promotes Trx-1 activity, and may inhibit TXNIP gene expression under oxidative stress or non-oxidative stress conditions. TXNIP acts as an intracellular Trx-1 repressor, inhibits the antioxidant activity of Trx-1, and promotes ROS production and apoptosis. Quercetin also acts as an effective iron chelator and scavenges free radicals including ROS and RNS.
Quercetin inhibits the activation and recruitment of the NF-κB transcription factor to pro-inflammatory genes and suppresses pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β. It also inhibits the PUFA-metabolizing enzyme lipoxygenase, blocking associated metabolites. Quercetin's anti-inflammatory action is caused by the inhibition of enzymes such as lipoxygenase and the inhibition of inflammatory mediators. It also inhibits the production and release of histamine and other allergic and inflammatory substances, possibly by stabilizing cell membranes of mast cells.
One of quercetin's most notable effects is its function as a senotherapeutic agent. It exhibits both senolytic (selectively eliminating senescent cells) and senomorphic (modulating the harmful effects of these cells) capabilities. For senolytic action, it triggers apoptosis in senescent cells by inhibiting anti-apoptotic proteins. For senomorphic effect, it functions by suppressing the senescence-associated secretory phenotype (SASP). These effects are specifically associated with the suppression of inflammatory pathways such as NF-κB and the NLRP3 inflammasome.
Quercetin blocks NF-κB activation and modulates the MAPK signaling pathway (P38, MAPK, ERK). It shifts macrophage polarization from pro-inflammatory M1 to anti-inflammatory M2 and inhibits T-lymphocyte proliferation and activation, regulating immune responses and alleviating autoimmune and inflammatory conditions.
Quercetin inhibits oxidative stress and inflammatory pathways, improves endothelial function, and reduces lipid accumulation. It lowers systolic blood pressure and concentrations of atherogenic oxidized LDL, reducing the risk of cardiovascular diseases including atherosclerosis, hypertension, and myocardial ischemia.
Quercetin regulates signaling pathways such as PI3K/AKT/mTOR, Wnt/β-catenin, and MAPK/ERK1. It enhances apoptosis and autophagy by activating CASP3, inhibits metastasis by reducing the secretion of MMP and VEGF, and downregulates mutant TP53 proteins, demonstrating selective toxicity targeting multiple cancer types.
Despite its broad pharmacological potential, quercetin presents significant formulation challenges. The compound is insoluble in water, has limited solubility in organic solvents, and has poor stability, especially under conditions of light, high temperature, and high humidity, where it is prone to oxidation and degradation reactions. After oral administration, its bioavailability is low due to its low solubility and easy metabolism in the gastrointestinal tract. Most quercetin may be metabolized by intestinal flora or excreted with feces before absorption, and the amount that can actually enter the blood circulation is limited.
liposomal encapsulation addresses these limitations through a phospholipid bilayer that protects quercetin from environmental degradation, improves its solubility and stability, and facilitates efficient cellular uptake. The phospholipid bilayer structure of liposomes can protect quercetin from the influence of the external environment while making it more dispersible in water, showing properties similar to colloidal solutions.
A randomized controlled trial evaluated the clinical efficacy of quercetin in 100 participants with Type 2 Diabetes Mellitus. Supplementation at 500 mg per day over 32 weeks resulted in reduced glycated hemoglobin (HbA1c) (−0.28%), reduced systolic blood pressure (−6.55 mmHg), improved lung function (FEV1 increase of 0.12 L), increased night-time sleep duration (+0.74 h), decreased anxiety levels, and significantly improved physical and mental quality of life.
A pilot Phase II clinical trial evaluated quercetin at 2,000 mg/day for 6 months in COPD patients. Plasma quercetin levels significantly increased after treatment. Levels of IL-8, IL-1β, and 8-isoprostane in bronchoalveolar lavage fluid and serum SP-D were significantly reduced. Quercetin also increased levels of CC16, which is considered to be anti-inflammatory and antioxidant in active smokers. Quercetin at 2,000 mg/day was safely tolerated by COPD patients.
Quercetin shows significant potential in gerontology and dermatology due to its comprehensive anti-aging effects. This activity targets the fundamental biological hallmarks of aging, specifically cellular senescence, oxidative stress, and chronic inflammation. One of quercetin's most notable effects is its function as a senotherapeutic agent, exhibiting both senolytic and senomorphic capabilities.
Liposomal encapsulation of quercetin provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the quercetin molecule, forming a shield that protects it from environmental degradation and enzymatic metabolism. This delivery system:
Protects quercetin from oxidation and degradation under light, heat, and humidity
Enhances solubility and water dispersibility
Improves cellular uptake through membrane fusion
Significantly enhances oral bioavailability
Liposomal quercetin is available as a sunflower phospholipid liposomal powder, supplied as a yellow fine powder. Quality control commonly focuses on active content, phospholipid carrier consistency, appearance, moisture, particle characteristics, microbial limits, heavy metals, and stability indicators.
Quercetin is generally well tolerated. Clinical trial research demonstrates that quercetin levels of up to 1 g per day are safe for consumption, and studies have safely tolerated doses up to 2,000 mg/day and 4,000 mg/day in specific patient populations. A Phase 1 study of quercetin for children and young adults with Fanconi anemia established a recommended dose with a maximum adult daily dose of 4,000 mg/d. The FDA has Generally Regarded as Safe (GRAS) status approved for 500 mg/day (GRN no. 341). Quercetin is widely commercialized as a dietary supplement ingredient. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.
This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.
119$/KG
99$/KG
RELATED
RELATED
RELATED
This website uses cookies to ensure you get the best experience on our website.
Comment
(0)